|1.||Li, Yixue: 1 article (04/2013)|
|2.||Hao, Pei: 1 article (04/2013)|
|3.||Ma, Chenchen: 1 article (04/2013)|
|4.||Li, Chunyan: 1 article (04/2013)|
|5.||Zheng, Lulu: 1 article (04/2013)|
|6.||Yu, Shuhao: 1 article (04/2013)|
|7.||Li, Xuan: 1 article (04/2013)|
|8.||Yu, Yang: 1 article (04/2013)|
|9.||Manns, Michael P: 1 article (07/2008)|
|10.||Steinmetz, Heinrich: 1 article (07/2008)|
04/10/2013 - "In contrast, Argyrin A had influence on cell cycle, and was involved in DNA damage repair at the same time, showing that Argyrin A was a more suitable drug for anti-cancer treatment. "
04/10/2013 - "We applied our methods to two drug candidates, Argyrin A and Bortezomib, both with anti-cancer activities. "
07/08/2008 - "Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition."
07/08/2008 - "In this issue of Cancer Cell, Nickeleit et al. (2008) identify a new proteasome inhibitor, argyrin A, and show that it induces apoptosis and inhibits angiogenesis via p27-dependent mechanisms. "
|1.||Proteasome Endopeptidase Complex (Proteasome)